• Home

  • About

  • Products & Services

    • OoCs

      • Single/Dual-Chamber Membrane Based Microfluidic Chip

      • High-Throughput Membrane-Based Microfluidic Chip

      • High-Throughput Membrane-Free Microfluidic Chip

      • High-Throughput Co-Culture Chip

      • Organ Chip Customization Service

    • Life Science Device

      • Organ Chip Intelligent Analysis System

      • Cell Imaging Environment Control System

      • Organ Chip Flow Controller

      • Organ Chip Flow Initiation Controller System

      • Skin chip intelligent analysis system

      • Liver chip intelligent analysis system

      • Fully automated skin chip intelligent workstation

      • Fully automated liver chip intelligent workstation

      • Ultrafast high-resolution three-dimensional organ chip online imaging and analysis system

    • Biomodels and Reagents

      • Cancer organoid Growth Kit

      • Human-derived organoid Growth Medium

      • Mouse Organoid Growth Kit

      • Model Culture Kit

      • Organoid Growth Relation Reagents

    • OoCs Solutions

      • Cancer Drug Sensitivity Analysis

      • IND Efficacy/Safety Evaluation

      • Evaluation of Functions/Safety of Cosmetics

      • Basic Scientific Research

  • News

    • Company News

    • Events

    • Industry News

    • Core News Network

    • Media Promotion

  • Careers

  • Contact

  • 中文版

 
 Language
中文 ENGLISH

Corporate Briefs

Events Pulse

Industry Insights

Chip Roundup

Media promotion

U.S. President Biden signed into law the FDA Modernization Act 2.0, eliminating federal mandatory requirement for animal testing for new and generic drugs


Release time:

2022-12-01 00:00

Source:


FDA通过现代化法案2.0,旨在减少药物开发过程中的动物实验


Previous Page

HRS-1893 tablets were approved for clinical trials, which is the first breakthrough of organoid data outside the realm of CGT drugs

General Technical Requirement of Skin-on-a-chip, China’s first draft technical standard for OoCs, was published

Next Page

Previous Page

HRS-1893 tablets were approved for clinical trials, which is the first breakthrough of organoid data outside the realm of CGT drugs

Next Page

General Technical Requirement of Skin-on-a-chip, China’s first draft technical standard for OoCs, was published

  • About AVATARGET

    • Company Profile

    • Corporate Culture

    • Development History

    • Patent Portfolio

    • Value Recognition

  • Products & Services

    • Single/Dual-Chamber Membrane Based Microfluidic Chip

    • Fully automated liver chip intelligent workstation

    • High-Throughput Membrane-Based Microfluidic Chip

    • Ultrafast high-resolution three-dimensional organ chip online imaging and analysis system

    • High-Throughput Membrane-Free Microfluidic Chip

    • Cancer organoid Growth Kit

    • High-Throughput Co-Culture Chip

    • Human-derived organoid Growth Medium

    • Organ Chip Customization Service

    • Mouse Organoid Growth Kit

    • Organ Chip Intelligent Analysis System

    • Model Culture Kit

    • Cell Imaging Environment Control System

    • Organoid Growth Relation Reagents

    • Organ Chip Flow Controller

    • Cancer Drug Sensitivity Analysis

    • Organ Chip Flow Initiation Controller System

    • IND Efficacy/Safety Evaluation

    • Skin chip intelligent analysis system

    • Evaluation of Functions/Safety of Cosmetics

    • Liver chip intelligent analysis system

    • Basic Scientific Research

    • Fully automated skin chip intelligent workstation

  • News

    • Company News

    • Events

    • Industry News

    • Core News Network

    • Media Promotion

  • Human Resource Development

    • Human Resource Development

    • Recruitment

  • Contact Us

    • Contact Information

    • Guestbook

    • Smart Map

Service Hotline(front desk)

+86 025-58858435

Picture Name

WeChat

Picture Name

Zhihu

Picture Name

Bilibili

©2023 Jiangsu Avatarget Biotechnology Co., Ltd. All rights reserved Website Construction:China Enterprise Power Kunshan SEO  

Business License

We use optional cookies to improve your experience on our website, including through social media connections, and to personalize ads based on your online activity. If you refuse optional cookies, we will only use cookies that are necessary to provide you with the services.Privacy Statement